| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, S Abrignani, R Addo, M Akdis, ... European journal of immunology 51 (12), 2708-3145, 2021 | 1775* | 2021 |
| Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells N Gagliani, CF Magnani, S Huber, ME Gianolini, M Pala, P Licona-Limon, ... Nature medicine 19 (6), 739-746, 2013 | 897 | 2013 |
| Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation N Gagliani, MCA Vesely, A Iseppon, L Brockmann, H Xu, NW Palm, ... Nature 523 (7559), 221-225, 2015 | 840 | 2015 |
| Regulation of TH17 cells and associated cytokines in wound healing, tissue regeneration, and carcinogenesis L Brockmann, AD Giannou, N Gagliani, S Huber International journal of molecular sciences 18 (5), 1033, 2017 | 151 | 2017 |
| A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease P Pelczar, M Witkowski, LG Perez, J Kempski, AG Hammel, L Brockmann, ... Science 354 (6310), 358-362, 2016 | 145 | 2016 |
| TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer LG Perez, J Kempski, HM McGee, P Pelzcar, T Agalioti, A Giannou, ... Nature communications 11 (1), 1-14, 2020 | 128 | 2020 |
| Molecular and functional heterogeneity of IL-10-producing CD4+ T cells L Brockmann, S Soukou, B Steglich, P Czarnewski, L Zhao, S Wende, ... Nature communications 9 (1), 1-14, 2018 | 124 | 2018 |
| IL-10 receptor signaling is essential for TR1 cell function in vivo L Brockmann, N Gagliani, B Steglich, AD Giannou, J Kempski, P Pelczar, ... The Journal of Immunology 198 (3), 1130-1141, 2017 | 123 | 2017 |
| TH17 cell and epithelial cell crosstalk during inflammatory bowel disease and carcinogenesis J Kempski, L Brockmann, N Gagliani, S Huber Frontiers in immunology 8, 1373, 2017 | 74 | 2017 |
| Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response M Piepke, BH Clausen, P Ludewig, JH Vienhues, T Bedke, E Javidi, ... Journal of neuroinflammation 18 (1), 1-16, 2021 | 36 | 2021 |
| IL22BP mediates the antitumor effects of lymphotoxin against colorectal tumors in mice and humans J Kempski, AD Giannou, K Riecken, L Zhao, B Steglich, J Lücke, ... Gastroenterology 159 (4), 1417-1430. e3, 2020 | 34 | 2020 |
| Probiotic-guided CAR-T cells for solid tumor targeting RL Vincent, CR Gurbatri, F Li, A Vardoshvili, C Coker, J Im, ER Ballister, ... Science 382 (6667), 211-218, 2023 | 30 | 2023 |
| Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22 AD Giannou, J Kempski, AM Shiri, J Lücke, T Zhang, L Zhao, DE Zazara, ... Immunity 56 (1), 125-142. e12, 2023 | 28 | 2023 |
| The role of c-FLIP splice variants in urothelial tumours F Ewald, N Ueffing, L Brockmann, C Hader, T Telieps, M Schuster, ... Cell death & disease 2 (12), e245-e245, 2011 | 28 | 2011 |
| CD4+ T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival N Yogev, T Bedke, Y Kobayashi, L Brockmann, D Lukas, T Regen, ... Cell Reports 38 (13), 110565, 2022 | 23 | 2022 |
| Role of IL-10 Receptor Signaling in the Function of CD4+ T-Regulatory Type 1 cells: T-Cell Therapy in Patients with Inflammatory Bowel Disease S Soukou, L Brockmann, T Bedke, N Gagliani, RA Flavell, S Huber Critical reviews™ in immunology 38 (5), 2018 | 20 | 2018 |
| Flt3 ligand expands bona fide innate lymphoid cell precursors in vivo SM Parigi, P Czarnewski, S Das, C Steeg, L Brockmann, ... Scientific reports 8 (1), 1-12, 2018 | 15 | 2018 |
| IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction AM Shiri, T Zhang, T Bedke, DE Zazara, L Zhao, J Lücke, M Sabihi, ... Journal of Hepatology 80 (4), 634-644, 2024 | 9 | 2024 |
| Intestinal microbiota-specific Th17 cells possess regulatory properties and suppress effector T cells via c-MAF and IL-10 L Brockmann, A Tran, Y Huang, M Edwards, C Ronda, HH Wang, II Ivanov Immunity, 2023 | 6 | 2023 |
| A Critical Role of the IL-22–IL-22 Binding Protein Axis in Hepatocellular Carcinoma AD Giannou, J Lücke, D Kleinschmidt, AM Shiri, B Steglich, M Nawrocki, ... Cancers 14 (24), 6019, 2022 | 4 | 2022 |
